U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

1-METHYL-5-MERCAPTOTETRAZOLE

MORE DETAILS

ZRB9LL6WTB

Status:
Other
Class (Stereo):
CHEMICAL (ACHIRAL)

CEFPIRAMIDE

MORE DETAILS

  P936YA152N

Status:
US Previously Marketed
Source:
CEFPIRAMIDE SODIUM by WYETH AYERST
(1989)
Source URL:
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=050633
First approved in 1989
Source:
CEFPIRAMIDE SODIUM by WYETH AYERST
Source URL:
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=050633
Class (Stereo):
CHEMICAL (ABSOLUTE)
Targets:
Bacterial penicillin-binding protein
233
Conditions:
Bacterial infections
234
Cefpiramide or SM-1652 (sodium 7-[D(-)-alpha-(4-hydroxy-6-methylpyridine-3-carboxamido)-alpha-(4-hydroxyphenyl)acetamido]-3-[(1-methyl-1H-tetrazol-5-yl) thiomethyl]-3-cephem-4-carboxylate) is a semisynthetic cephalosporin derivative with a broad spectrum of antibacterial activity. This antibiotic has been reported to have potent in vitro and in vivo antibacterial activities against gram-positive and -negative bacteria.

CEFPIRAMIDE SODIUM

MORE DETAILS

  137KB7GYKB

Status:
US Previously Marketed
Source:
CEFPIRAMIDE SODIUM by WYETH AYERST
(1989)
Source URL:
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=050633
First approved in 1989
Source:
CEFPIRAMIDE SODIUM by WYETH AYERST
Source URL:
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=050633
Class (Stereo):
CHEMICAL (ABSOLUTE)
Targets:
Bacterial penicillin-binding protein
233
Conditions:
Bacterial infections
234
Cefpiramide or SM-1652 (sodium 7-[D(-)-alpha-(4-hydroxy-6-methylpyridine-3-carboxamido)-alpha-(4-hydroxyphenyl)acetamido]-3-[(1-methyl-1H-tetrazol-5-yl) thiomethyl]-3-cephem-4-carboxylate) is a semisynthetic cephalosporin derivative with a broad spectrum of antibacterial activity. This antibiotic has been reported to have potent in vitro and in vivo antibacterial activities against gram-positive and -negative bacteria.
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966